Italia markets open in 4 hours 59 minutes

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqCM - NasdaqCM Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,7701+0,1101 (+4,14%)
Alla chiusura: 04:00PM EDT

Transazioni interne

Valuta in USD
Acquisti degli insider negli ultimi 6 mesiAzioniTrans
Acquisti00
VenditeN/D0
Saldo azioni acquistate (vendute)00
Totale di azioni possedute dagli insider593,59kN/D
% saldo azioni acquistate (vendute)N/DN/D
Acquisti al netto degli investitori istituzionali del trimestre precedente fino all'ultimo trimestreAzioni
Saldo azioni acquistate (vendute)N/D
% variazione nelle azioni possedute da investitori istituzionaliN/D

Compravendite insider riportate - ultimi due anni

InsiderTransazioneTipoValoreDataAzioni

HECHT PETER M
Director and Beneficial Owner of more than 10% of a Class of Security

Stock Award(Grant) at price 0.00 per share.Diretto029 dic 202315.000

GRAUL REGINA MARGARET
President

Stock Award(Grant) at price 0.00 per share.Diretto029 dic 202350.000

HECHT PETER M
Director and Beneficial Owner of more than 10% of a Class of Security

Stock Award(Grant) at price 0.00 per share.Diretto001 dic 202335.000

DESOUZA ERROL B
Director

Stock Award(Grant) at price 0.00 per share.Diretto030 nov 202350.000

HYMAN STEVEN
Director

Stock Award(Grant) at price 0.00 per share.Diretto030 nov 202320.000

MCGUIRE TERRANCE G
Director

Stock Award(Grant) at price 0.00 per share.Diretto030 nov 20235.000

MCGUIRE TERRANCE G
Director

Sale at price 3.40 per share.Indiretto2709 ago 20238

HECHT PETER M
Chief Executive Officer

Stock Award(Grant) at price 5.26 per share.Diretto1.183.50019 mag 2023225.000

HECHT PETER M
Chief Executive Officer

Purchase at price 3.28 per share.Diretto2.699.99803 giu 2021823.170

MCGUIRE TERRANCE G
Director

Purchase at price 3.12 per share.Indiretto299.99703 giu 202196.153

SLATE PATH CAPITAL LP
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 3.12 per share.Indiretto2.999.99903 giu 2021961.538

HECHT PETER M
Chief Executive Officer

Purchase at price 2.43 per share.Diretto733.86006 mag 2021302.000

HECHT PETER M
Chief Executive Officer

Purchase at price 2.29 - 2.53 per share.Diretto1.693.94305 mag 2021698.001

WRIGHT CHRISTOPHER I
Officer

Sale at price 3.99 per share.Diretto10.52225 feb 20212.637

GJINO ANJEZA
Chief Financial Officer

Sale at price 4.00 per share.Diretto7.29625 feb 20211.824

CURRIE MARK G
President

Sale at price 3.01 per share.Diretto60.52228 dic 202020.107

BUSCH ANDREAS
Officer

Purchase at price 2.53 per share.Diretto316.25009 nov 2020125.000

HUYETT WILLIAM
Chief Financial Officer

Sale at price 2.52 per share.Diretto9.64406 nov 20203.827

HUYETT WILLIAM
Chief Financial Officer

Sale at price 5.12 per share.Diretto18.22221 feb 20203.559

CURRIE MARK G
President

Sale at price 2.48 - 2.55 per share.Diretto125.75030 dic 201950.000

BUSCH ANDREAS
Chief Technology Officer

Purchase at price 1.82 per share.Diretto227.50015 nov 2019125.000

HUYETT WILLIAM
Chief Financial Officer

Sale at price 2.05 per share.Diretto8.04008 nov 20193.922

HECHT PETER M
Chief Executive Officer

Conversion of Exercise of derivative security at price 6.04 per share.Diretto12.08010 lug 20192.000

SCHULMAN AMY W.
Director

Purchase at price 16.00 per share.Indiretto10.017.87208 apr 2019626.117

MCGUIRE TERRANCE G
Director

Purchase at price 16.00 per share.Indiretto10.017.87208 apr 2019626.117

CURRIE MARK G
President

Purchase at price 14.81 per share.Diretto4.000.28502 apr 2019270.107

CURRIE MARK G
President

Purchase at price 14.81 per share.Diretto4.000.28502 apr 2019270.107

CONRADES GEORGE HENRY
Director

Stock Award(Grant) at price 0.00 per share.Diretto001 apr 20192.421

CONRADES GEORGE HENRY
Director

Diretto01 apr 20192.421

FANUCCI MARSHA H
Director

Stock Award(Grant) at price 0.00 per share.Diretto001 apr 201916.950

FANUCCI MARSHA H
Director

Diretto01 apr 201916.950

SCHULMAN AMY W.
Director

Diretto01 apr 20197.508

HECHT PETER M
Chief Executive Officer

Indiretto01 apr 2019223.191

HECHT PETER M
Chief Executive Officer

Indiretto01 apr 2019224.647

CURRIE MARK G
President

Diretto01 apr 201951.648

CURRIE MARK G
President

Diretto01 apr 201951.648

MENDELSOHN MICHAEL E
Director

Diretto01 apr 20192.421

MCGUIRE TERRANCE G
Director

Indiretto01 apr 201918.120

HUYETT WILLIAM
Chief Financial Officer

Diretto01 apr 201977.492

HUYETT WILLIAM
Chief Financial Officer

Diretto01 apr 201977.506

CHURCHWELL KEVIN
Director

Diretto01 apr 20192.421

ISACSON OLE
Director

Diretto01 apr 20192.421

LOVELL STEPHANIE
Director

Diretto01 apr 20192.421

IRONWOOD PHARMACEUTICALS INC.
Beneficial Owner of more than 10% of a Class of Security

Diretto29 mar 201915.562.455